跳至主要内容
临床试验/NCT00306085
NCT00306085Unknown1 期

Autologous Bone Marrow Cell Treatment in Patients With Peripheral Atherosclerosis

University of Naples2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2005年4月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
20
试验地点
2
主要终点
Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.

研究概览

简要总结

Implantation of bone marrow cells, including endothelial progenitor cells, into ischemic limbs has been shown to improve collateral vessel formation. In the present study the safety and feasibility of autologous blood mononuclear cells implantation will be investigated in patients with severe peripheral atherosclerosis.Twenty cases will be enrolled. Improvement in the ankle-brachial pressure index (ABI:>0.1), ischemic ulcers and angiography as well as laser doppler flow will be evaluated until six months.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
45 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of third or fourth class of peripheral atherosclerosis

排除标准

  • Insuline dependent diabetes

结局指标

主要结局

Clinical and instrumental indexes of functional impairment of peripheral atherosclerosis.

次要结局

  • Angiographic and laser doppler measurements after six months from treatment.

研究者

发起方
University of Naples
申办方类型
Other

研究点 (2)

Loading locations...

相似试验